Financials

News Ideas Discussions Technicals Seasonals

Net income before discontinued operations of MACRO GROUP PHARMACEUTICALS -MACRO CAPITAL

Annual data

2022

2023

TTM

‪‪−300.00 M‬‬

‪‪−150.00 M‬‬

‪0.00‬

‪‪150.00 M‬‬

‪‪300.00 M‬‬

Period

Value

Change

Change %

TTM

—

—

—

2023

‪‪−272.65 M‬‬

‪‪−446.49 M‬‬

‪−256.84‬%

2022

‪‪173.84 M‬‬

+‪‪25.91 M‬‬

+‪17.51‬%

Quarterly data

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q2 '24

‪‪−25.00 M‬‬

‪0.00‬

‪‪25.00 M‬‬

‪‪50.00 M‬‬

‪‪75.00 M‬‬

Period

Value

Change

Change %

Q2 '24

‪‪−10.69 M‬‬

‪‪−79.44 M‬‬

‪−115.54‬%

Q3 '23

‪‪68.75 M‬‬

+‪‪48.86 M‬‬

+‪245.62‬%

Q2 '23

‪‪19.89 M‬‬

+‪‪10.45 M‬‬

+‪110.62‬%

Q1 '23

‪‪9.44 M‬‬

‪‪−34.94 M‬‬

‪−78.72‬%

Q4 '22

‪‪44.39 M‬‬

‪‪−13.71 M‬‬

‪−23.60‬%

Q3 '22

‪‪58.10 M‬‬

+‪‪17.42 M‬‬

+‪42.82‬%

Q2 '22

‪‪40.68 M‬‬

+‪‪10.01 M‬‬

+‪32.65‬%

Q1 '22

‪‪30.67 M‬‬

‪‪−10.47 M‬‬

‪−25.44‬%